Kite Pharma Deepens Cell Manufacturing and Operations Expertise with Appointment of Tim Moore
Mar 16, 2016 11:30 am UTC| Business
SANTA MONICA, Calif., March 16, 2016 -- Kite Pharma, Inc. (Nasdaq:KITE) today announced the appointment of Tim Moore as Executive Vice President, Technical Operations. With more than three decades of industry...
Claes Glassell Appointed to the Board of Directors of Cambrex Corporation
Mar 16, 2016 11:30 am UTC| Business
EAST RUTHERFORD, N.J., March 16, 2016 -- Cambrex Corporation (NYSE:CBM) (“Cambrex”) announced today that on March 14, 2016, Claes Glassell was appointed to the Company’s Board of Directors for a term expiring on the...
Mar 16, 2016 11:00 am UTC| Business
New Agreement Follows Dr. David B. Weiner’s Move to Wistar from the University of Pennsylvania (UPenn) Inovio will maintain all existing license agreements with UPenn PLYMOUTH MEETING, Pa., March 16, 2016 -- Inovio...
CareTrust REIT, Inc. Increases Quarterly Dividend to $0.17 per Share
Mar 16, 2016 11:00 am UTC| Business
SAN CLEMENTE, Calif., March 16, 2016 -- CareTrust REIT, Inc. (NASDAQ:CTRE) today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of CareTrust common stock, payable on...
Mar 16, 2016 11:00 am UTC| Business
NEW YORK, March 16, 2016 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral,...
Mar 16, 2016 11:00 am UTC| Business
EWING, N.J., March 16, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced 12 week efficacy and 52 week safety results from the phase 3 clinical study (QST-13-003) evaluating testosterone enanthate administered...
Mar 16, 2016 11:00 am UTC| Business
Trial marks the final clinical milestone on the pathway to pursue a broaderFeraheme®label WALTHAM, Mass., March 16, 2016 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has enrolled the first...